I brought it up to compare the good times with FITX when it had gone from .002 to over .12+ per share while having far less potential than what exists here with BLDV.
FITX never got past Step 1 with obtaining approval from Health Canada.
AMS has gotten far past Step 1 and has actually completed Step 6 and is now working towards Step 7.
The main point is that if FITX with far less going on with it back then than what we have here with BLDV can go to .12+ per share with a very similar share structure as BLDV's, then I think we are still at the bottom here with BLDV with what the market will eventually see here with BLDV.
Bottom line... we are comparing "the good vs the good" between the two stocks.
News 
Market Data 
Discover 
